Why NGS ELN deployments fail
Next-generation sequencing (NGS) has become indispensable in biopharmaceutical research, enabling breakthroughs in personalized medicine, gene therapy and genomics. However, labs often struggle with failed ELN (electronic laboratory notebook) deployments that derail NGS workflows.
Based on insights from our NGS informatics experts who regularly hear these complaints, this White Paper summarizes all the critical mistakes to avoid.
Download this White Paper to understand more about mistakes to avoid, including:
- Selecting generic electronic lab notebook solutions
- Over-customizing rigid platforms
- Deploying fragmented laboratory systems
- Ignoring scalability and real-time monitoring
- And more…
About Sapio Sciences
Sapio Sciences’ mission is to improve lives by accelerating discovery, and because science is complex, Sapio makes technology simple. Sapio is a global business offering an all-in-one science-awareTM lab informatics platform combining cloud-based LIMS, ELN, and Jarvis data solutions.
Sapio serves some of the largest global and specialist brands, including biopharma, CRO/CDMOs and clinical diagnostic labs across NGS genomic sequencing, bioanalysis, bioprocessing, chemistry, stability, histopathology, and in vivo studies.
Customers love Sapio’s platform because it is robust, scalable, and with no-code configuration, can quickly adapt to meet unique needs. For more information, visit www.sapiosciences.com and follow us on LinkedIn.
In association with:
Our expert opinion collection provides you with in-depth articles written by authors from across the field of bioanalysis. Our expert opinions are perfect for those wanting a comprehensive, written review of a topic or looking for perspective pieces from our regular contributors.
See an article that catches your eye? Read any of our articles below for free.
